STEVANATO GROUP SPA
(NYSE: STVN)

Stevanato Group SpA engages in the provision of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It operates through the following segments: Biopharmaceutical and Diagnostic Solutions, and Engineering segments. The Biopharmaceutical and Diagnostic Solutions segment includes all the products, processes, and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables. The Engineering segment deals with all the equipment and technologies developed and provided to support the end-to-end pharmaceutical, biotechnology and diagnostic manufacturing processes. The company was founded by Giovanni Stevanato in 1949 and is headquartered in Piombino Dese, Italy.

19.590

+0.580 (+3.05%)
Range 18.995 - 20.270   (6.71%)
Open 19.050
Previous Close 19.010
Bid Price 19.000
Bid Volume 12
Ask Price 19.260
Ask Volume 10
Volume 488,679
Value -
Remark
Delayed prices. Updated at 02 Nov 2024 04:00.
Data powered by
View All Events

Loading Chart...

Please login to view stock data and analysis